Novel high relaxivity colloidal particles based on the specific phase organisation of amphiphilic gadolinium chelates with cholesterol

International Journal of Pharmaceutics

Volumn 253, Issue 1-2, 2003, Pages 39-48

  Gløgård, Christian ^a   Stensrud, Gry ^b   Klaveness, Jo ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b Pharmaceutical Process Development   (Norway)

Author keywords

Gadolinium chelates; Lipid disc; MR contrast agent; Particles

Indexed keywords

CHOLESTEROL; GADOLINIUM 1,4,7 (CARBOXYMETHYL) 10 (2 HYDROXYHEXADECYL) 1,4,7,10 TETRAAZACYCLODODECANE; GADOLINIUM CHELATE; PALMITIC ACID; UNCLASSIFIED DRUG;

ARTICLE; COLLOID; CRYOELECTRON MICROSCOPY; DRUG DOSAGE FORM; DRUG FORMULATION; DRUG RESEARCH; DRUG STABILITY; EXPERIMENTAL MODEL; PRIORITY JOURNAL; ROOM TEMPERATURE; SHELF LIFE; THERMODYNAMICS; THERMOSTABILITY;

EID: 12344333491     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(02)00635-X     Document Type: Article

References (14)

1. Almgren M., Edwards K., Karlsson G. Cryo transmission electron microscopy of liposomes and related structures. Colloid Surf. A: Physicochem. Eng. Aspects. 174:2000;3-21.
2. André J.P., Tóth É., Fischer H., Seelig A., Mäcke H.R., Merbach A.E. High relaxivity for monomeric Gd(DOTA)-based MRI contrast agents, thanks to micellar self-organization. Chem. Eur. J. 5:1999;2977-2983.
3. Caravan P., Ellison J.J., McMurry T.J., Lauffer R.B. Gadolinium(III) chelates as MRI contrast agents: structure, dynamics, and applications. Chem. Rev. 99:1999;2293-2352.
4. Edwards K., Johnsson M., Karlsson G., Silvander M. Effect of polyethyleneglycol-phospholipids on aggregate structure in preparations of small unilamellar liposomes. Biophys. J. 73:1997;258-266.
5. Esbensen, K.H., 2000. Multivariate data analysis in practice, 4th ed. Camo ASA, Oslo, Norway.
6. Fossheim S.L., Kellar K.E., Månsson S., Colet J.-M., Rongved P., Fahlvik K., Klaveness J. Investigation of lanthanide-based starch particles as a model system for liver contrast agents. J. Magn. Reson. Imaging. 9:1999;295-303.
7. Gløgård C., Hovland R., Fossheim S.L., Aasen A.J., Klaveness J. Synthesis and physiochemical characterisation of new amphiphilic gadolinium DO3A complexes as contrast agents for MRI. J. Chem. Soc. Perkin Trans. 2:2000;1047-1052.
8. Gløgård C., Stensrud G., Hovland R., Fossheim S.L., Klaveness J. Liposomes as carriers of amphiphilic gadolinium chelates: the effect of membrane composition on incorporation efficacy and in vitro relaxivity. Int. J. Pharm. 233:2002;131-140.
9. Guo L.S.S., Fielding R.M., Lasic D.D., Hamilton R.L., Mufson D. Novel antifungal drug delivery: stable amphotericin B-cholesteryl sulfate discs. Int. J. Pharm. 75:1991;45-54.
10. Hillery A.M. Supramolecular lipidic drug delivery systems: from laboratory to clinic. A review of the recently introduced commercial liposomal and lipid-based formulations of amphotericine B. Adv. Drug Deliv. Rev. 24:1997;345-363.
11. Israelachvili J.N., Marcelja S., Horn R.G. Physical principles of membrane organization. Q. Rev. Biophys. 13:1980;121-200.
12. Kabalka G.W., Davis M.A., Moss T.H., Buoenocore E., Hubner K., Holmberg E., Maruyama K., Huang L. Gadolinium labeled liposomes containing various amphiphilic Gd-DTPA derivates: targeted MRI contrast agents for the liver. Magn. Reson. Med. 19:1991;406-415.
13. Morel S., Terreno E., Ugazio E., Aime S., Gasco M.R. NMR relaxometric investigations of solid lipid nanoparticles (SLN) containing gadolinium(III) complexes. Eur. J. Pharm. Biopharm. 45:1998;157-163.
14. Storrs R.W., Tropper F.D., Li H.Y., Henry Y., Song C.K., Kuniyoshi J.K., Sipkins D.A., Kuniyoshi J.K., Bednarski M.D., Strauss H.W., Li K.C.P. Paramagnetic polymerized liposomes as new recirculating MR contrast agents. J. Magn. Reson. Imaging. 117:1995;719-724.